CSIMarket
 
Arrivent Biopharma inc   (NASDAQ: AVBP)
 

Arrivent Biopharma Inc's Customers Performance

AVBP



 
AVBP's Source of Revenues

List of AVBP Customers




for the same period Arrivent Biopharma Inc

List of AVBP Customers





Arrivent Biopharma Inc's Comment on Sales, Marketing and Customers



The company serves customers who bill federal programs for pharmaceutical products, including authorized users of the Federal Supply Schedule of the General Services Administration. Its market segments include federal programs, Medicaid, Medicare, physicians, teaching hospitals, and certain advanced non-physician health care practitioners. The company complies with laws affecting sales to these customers, such as the Physician Payments Sunshine Act and various state laws related to payments to healthcare providers and marketing expenditures.


  News about Arrivent Biopharma inc Contracts

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

Overview of ArriVent and Alphamab s Multi-Target ADC CollaborationIn a groundbreaking development within the pharmaceutical industry, ArriVent has recently announced a strategic collaboration with Alphamab. This partnership aims to leverage Alphamab s advanced antibody-drug conjugate (ADC) research and discovery platform in conjunction with ArriVent s global expertise in drug development and commercialization. Key Components of the CollaborationThe core of this collaboration is to create and develop multiple ADCs targeting specific oncological markers, thereby enhancing the efficacy and precision of cancer treatment modalities. The collaboration will focus on several critical aspects:1. Antibody-Drug Con...




Arrivent Biopharma Inc’s Comment on Sales, Marketing and Customers


The company serves customers who bill federal programs for pharmaceutical products, including authorized users of the Federal Supply Schedule of the General Services Administration. Its market segments include federal programs, Medicaid, Medicare, physicians, teaching hospitals, and certain advanced non-physician health care practitioners. The company complies with laws affecting sales to these customers, such as the Physician Payments Sunshine Act and various state laws related to payments to healthcare providers and marketing expenditures.








AVBP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Arrivent Biopharma inc 1,350.61 0.00 -145.24 77
SUBTOTAL 0.00 0.00 0.00 -

Sources: Arrivent Biopharma inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Arrivent Biopharma inc’s corporate clients.
For your research, we’ve provided 9 tables on Arrivent Biopharma inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.